Clinical Trials Browser

Parkinsonian Disorders × Magnetic Resonance Spectroscopy × 90 days × Clear all

NCT07542158 2026-04-21

Ultralow Dose PET Imaging of 18F-FDOPA

Phase 2 Enrolling by invitation

Glioma, Neoplasms, Parkinsonian Disorders